Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Blarcamesine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Anavex Life Sciences Provides Regulatory Update on Blarcamesine
    Anavex Life Sciences Provides Regulatory Update on Blarcamesine

    14 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/14/3188222/29248/en/Anavex-Life-Sciences-Provides-Regulatory-Update-on-Blarcamesine-for-Early-Alzheimer-s-Disease.html

    GLOBENEWSWIRE
    14 Nov 2025
    Share Share
    Anavex Oral Blarcamesine Shows Ongoing Benefit in Alzheimer
    Anavex Oral Blarcamesine Shows Ongoing Benefit in Alzheimer

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176310/29248/en/Anavex-Life-Sciences-Announces-Continued-Long-Term-Benefit-from-Oral-Blarcamesine-Compared-to-Decline-Observed-in-the-Alzheimer-s-Disease-Neuroimaging-Initiative-ADNI-Control-Group.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share
    Anavex Life Sciences Presents At 35th Alzheimer Europe Conference
    Anavex Life Sciences Presents At 35th Alzheimer Europe Conference

    10 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/10/3164794/29248/en/Anavex-Life-Sciences-Announces-Presentation-at-the-35th-Alzheimer-Europe-Conference-Connecting-Science-and-Communities-The-Future-of-Dementia-Care.html

    GLOBENEWSWIRE
    10 Oct 2025
    Share Share
    Anavex Publishes Blarcamesine Ph IIb/III Alzheimer’s Results
    Anavex Publishes Blarcamesine Ph IIb/III Alzheimer’s Results

    30 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/30/3158599/29248/en/Anavex-Life-Sciences-Announces-Publication-of-Oral-Blarcamesine-Describing-a-New-Class-of-Clinical-Precision-Medicine-from-Phase-IIb-III-Alzheimer-s-Disease-Trial.html

    GLOBENEWSWIRE
    30 Sep 2025
    Share Share
    Anavex Reveals Blarcamesine Results in Ph 2b/3 Alzheimer’s Trial
    Anavex Reveals Blarcamesine Results in Ph 2b/3 Alzheimer’s Trial

    09 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/09/3146779/29248/en/Anavex-Life-Sciences-Announces-Oral-Blarcamesine-Cognitive-Resilience-Results-Approximating-Normal-Aging-in-New-Precision-Medicine-Clinical-Data-from-Phase-IIb-III-Alzheimer-s-Dise.html

    GLOBENEWSWIRE
    09 Sep 2025
    Share Share
    Anavex Reports Journal on Autophagy Mechanism with Blarcamesine
    Anavex Reports Journal on Autophagy Mechanism with Blarcamesine

    26 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/26/3139157/29248/en/Anavex-Life-Sciences-Reports-New-Publication-in-Medical-Journal-Highlighting-the-Established-Precise-Autophagy-Mechanism-with-Blarcamesine.html

    GLOBENEWSWIRE
    26 Aug 2025
    Share Share